Pharmacotherapy and Patient Care in Rheumatoid Arthritis

Dear Colleagues,

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent synovial inflammation, progressive joint destruction, and significant impacts on quality of life. Over recent decades, advances in pharmacotherapy—including conventional synthetic DMARDs, biologic agents, and targeted synthetic therapies—have transformed RA management. However, challenges remain in optimizing treatment strategies, managing comorbidities, addressing drug safety, and tailoring therapy to individual patient profiles.

This Special Issue of the Journal of Clinical Medicine aims to bring together high-quality original research and comprehensive reviews addressing all aspects of pharmacotherapy and patient care in RA. Topics of interest include, but are not limited to, the following:

• Comparative effectiveness and safety of current and emerging treatments;
• Biomarkers and precision medicine approaches for therapeutic decision making;
• Management of treatment-resistant RA;
• Strategies for minimizing adverse effects and improving adherence;
• Multidisciplinary care models and patient-centered approaches;
• Impact of lifestyle and rehabilitation on treatment outcomes.

By integrating insights from clinical trials, real-world studies, and translational research, this Special Issue seeks to advance the understanding of optimal RA management and improve patient care. We welcome submissions from clinicians, researchers, and healthcare professionals across disciplines.

Dr. Ryu Watanabe
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.